We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
BridgeBio Pharma
BBIO
$16.1B
| $55.3M | 0.42% |
+777,031
| New | +$37.5M |
|
52
Mastercard
MA
$500B
| $54.9M | 0.42% |
153,933
+18,356
| +14% | +$6.11M |
|
53
UnitedHealth
UNH
$375B
| $54.7M | 0.41% |
156,076
+4,890
| +3% | +$1.64M |
|
54
Merck
MRK
$317B
| $54.4M | 0.41% |
697,164
+41,241
| +6% | +$3.15M |
|
55
Honeywell
HON
$78.6B
| $54.3M | 0.41% |
270,750
+17,004
| +7% | +$3.09M |
|
56
Invesco QQQ Trust
QQQ
$480B
| $54.3M | 0.41% |
172,962
+7,900
| +5% | +$2.32M |
|
57
Costco
COST
$418B
| $54.1M | 0.41% |
143,512
+29,115
| +25% | +$10.9M |
|
58
Regeneron Pharmaceuticals
REGN
$79.1B
| $52.5M | 0.4% |
108,621
+4,041
| +4% | +$2.18M |
|
59
Nike
NKE
$63B
| $52.5M | 0.4% |
370,891
+22,659
| +7% | +$3M |
|
60
Oracle
ORCL
$416B
| $51.8M | 0.39% |
801,259
-12,204
| -2% | -$726K |
|
61
Alnylam Pharmaceuticals
ALNY
$30.6B
| $50.5M | 0.38% |
388,745
+3,949
| +1% | +$527K |
|
62
Trimble
TRMB
$13.7B
| $50M | 0.38% |
748,200
-7,158
| -0.9% | -$411K |
|
63
Vanguard Information Technology ETF
VGT
$147B
| $49.3M | 0.37% |
1,113,672
+5,456
| +0.5% | +$224K |
|
64
Illumina
ILMN
$30.2B
| $48M | 0.36% |
133,487
+1,042
| +0.8% | +$332K |
|
65
Comcast
CMCSA
$87.8B
| $47.8M | 0.36% |
911,908
+50,499
| +6% | +$2.42M |
|
66
Chevron
CVX
$371B
| $46.4M | 0.35% |
549,934
-94,053
| -15% | -$7.62M |
|
67
Warner Music
WMG
$13.6B
| $46.2M | 0.35% |
+1,217,236
| New | +$37.1M |
|
68
Omnicell
OMCL
$1.69B
| $46.1M | 0.35% |
384,414
-67,546
| -15% | -$6.62M |
|
69
First Solar
FSLR
$25.4B
| $46.1M | 0.35% |
465,552
+4,999
| +1% | +$433K |
|
70
McDonald's
MCD
$195B
| $44.3M | 0.34% |
206,562
+12,938
| +7% | +$2.81M |
|
71
Tesla
TSLA
$1.27T
| $43.1M | 0.33% |
183,234
+39,516
| +27% | +$6.74M |
|
72
NVIDIA
NVDA
$5.31T
| $43.1M | 0.33% |
3,300,160
+1,041,760
| +46% | +$13.9M |
|
73
iShares Core MSCI EAFE ETF
IEFA
$194B
| $42.6M | 0.32% |
617,045
+90,297
| +17% | +$5.84M |
|
74
Vanguard FTSE Developed Markets ETF
VEA
$234B
| $42.6M | 0.32% |
901,868
+193,411
| +27% | +$8.51M |
|
75
Starbucks
SBUX
$121B
| $42.2M | 0.32% |
394,093
+19,406
| +5% | +$1.85M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.